We are live on
!
Find out more
PG
Prostatis Group Portfolio holdings
AUM
$391M
1-Year Est. Return
20.37%
This Fund
S&P 500
This Quarter
Est. Return
+8.71%
1 Year Est. Return
+20.37%
3 Year Est. Return
+56.13%
5 Year Est. Return
+74.88%
10 Year Est. Return
–
AUM
$164M
AUM Growth
+$77.1M
(+89%)
Cap. Flow
+$71.4M
Cap. Flow
% of AUM
43.55%
Top 10 Holdings %
Top 10 Hldgs %
45.49%
Holding
112
New
48
Increased
28
Reduced
19
Closed
15
Top Buys
| 1 |
Vanguard Value ETF
VTV
|
+$16.6M |
| 2 |
ProShares Short S&P500
SH
|
+$9.7M |
| 3 |
Vanguard Total International Stock ETF
VXUS
|
+$6.7M |
| 4 |
Vanguard Mid-Cap ETF
VO
|
+$6.45M |
| 5 |
FT Vest US Equity Enhance & Moderate Buffer ETF December
XDEC
|
+$4.65M |
Top Sells
| 1 |
Invesco S&P 500 GARP ETF
SPGP
|
+$5.24M |
| 2 |
Invesco S&P MidCap Momentum ETF
XMMO
|
+$4.01M |
| 3 |
FT Vest Fund of Deep Buffer ETFs
BUFD
|
+$3.52M |
| 4 |
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
|
+$2.79M |
| 5 |
Pacer Lunt Large Cap Multi-Factor Alternator ETF
PALC
|
+$2.65M |
Sector Composition
| 1 | Healthcare | 3.63% |
| 2 | Technology | 2.33% |
| 3 | Industrials | 1.89% |
| 4 | Financials | 1.78% |
| 5 | Energy | 1.58% |
Similar funds
S
RI
CFA
SI
MA
TCM
IPW
HP
Prostatis Group's Q4 2022 Portfolio in Review
As of Q4 2022, Prostatis Group held 112 positions worth $164M, up 89% from $86.8M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Prostatis Group deployed $71.4M of net new capital in Q4 2022, opening 48 new positions and adding to 28 existing holdings. Its largest new stake was Vanguard Value ETF: 120,222 shares worth $16.9M.
By sector, the portfolio is most concentrated in Healthcare at 3.6% of assets, down from 6% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Invesco S&P 500 GARP ETF, an estimated $5.24M trimmed.
- Prostatis Group's largest Q4 2022 buy was Vanguard Value ETF: 120,222 shares worth $16.9M.
- Prostatis Group added most to State Street Health Care Select Sector SPDR ETF in Q4 2022, an estimated $2.47M increase.
- Prostatis Group's biggest Q4 2022 reduction was Invesco S&P 500 GARP ETF, cutting an estimated $5.24M.
- Prostatis Group fully exited Invesco S&P MidCap Momentum ETF in Q4 2022, selling an estimated $4.01M.
- Prostatis Group's ten largest holdings make up 45% of its $164M portfolio in Q4 2022.
- Prostatis Group opened 48 new positions and closed 15 in Q4 2022.
- Prostatis Group's portfolio value rose 89% quarter-over-quarter to $164M.
Based on Prostatis Group's 13F filing for Q4 2022, filed 23 Mar 2023.